These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 3654953

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Preliminary disk diffusion susceptibility testing criteria for cefdaloxime (RU29246, HR-916 metabolite), a new orally administered cephalosporin.
    Jones RN, Erwin ME.
    J Clin Microbiol; 1992 May; 30(5):1297-300. PubMed ID: 1583135
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Evaluation of the cefonicid disk test criteria, including disk quality control guidelines.
    Barry AL, Jones RN, Thornsberry C.
    J Clin Microbiol; 1983 Feb; 17(2):232-9. PubMed ID: 6601113
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Antimicrobial activity of Ro 19-5247 (T-2525), a new oral cephalosporin, tested against 7,745 recent clinical isolates.
    Jones RN, Fuchs PC, Barry AL, Ayers LW, Gerlach EH, Gavan TL.
    Diagn Microbiol Infect Dis; 1987 Mar; 6(3):193-8. PubMed ID: 3568594
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The activity of the 4 quinolone Ro 23 6240 and the cephalosporins Ro 15 8074 and Ro 19 5247 against penicillin sensitive and resistant gonococci.
    Easmon CS, Woodford N, Ison CA.
    J Antimicrob Chemother; 1987 Jun; 19(6):761-5. PubMed ID: 3112100
    [Abstract] [Full Text] [Related]

  • 37. MIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacin.
    Erwin ME, Jones RN, Koontz FP, Gerlach EH, Murray PR, Washington JA.
    J Clin Microbiol; 1992 May; 30(5):1317-9. PubMed ID: 1316371
    [Abstract] [Full Text] [Related]

  • 38. Disk agar diffusion susceptibility testing with 30-micrograms ceftazidime disks: confirmation of interpretive breakpoints and quality control guidelines.
    Jones RN, Barry AL, Thornsberry C.
    J Clin Microbiol; 1983 Jul; 18(1):211-4. PubMed ID: 6350348
    [Abstract] [Full Text] [Related]

  • 39. In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) against Mycobacterium fortuitum and Mycobacterium chelonae.
    Hohl P, Salfinger M, Kafader FM.
    Eur J Clin Microbiol; 1987 Aug; 6(4):487-8. PubMed ID: 3117539
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.